Patents by Inventor Martine JASSON

Martine JASSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME
    Publication number: 20210230719
    Abstract: The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R) with a DMARD.
    Type: Application
    Filed: December 24, 2020
    Publication date: July 29, 2021
    Inventors: Xiaohong Huang, Martine Jasson, Vanessa Marks, Allen Radin
  • Compositions for the treatment of rheumatoid arthritis and methods of using same
    Patent number: 10927435
    Abstract: The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R) with a DMARD.
    Type: Grant
    Filed: October 10, 2012
    Date of Patent: February 23, 2021
    Assignees: SANOFI BIOTECHNOLOGY, REGENERON PHARMACEUTICALS, INC.
    Inventors: Xiaohong Huang, Martine Jasson, Vanessa Marks, Allen Radin
  • COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME
    Publication number: 20180296670
    Abstract: The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R).
    Type: Application
    Filed: March 2, 2018
    Publication date: October 18, 2018
    Inventors: Martine JASSON, Vanessa MARKS, Xiaohong HUANG, Allen RADIN
  • Methods for the treatment of rheumatoid arthritis
    Patent number: 9943594
    Abstract: The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R).
    Type: Grant
    Filed: October 10, 2012
    Date of Patent: April 17, 2018
    Assignees: SANOFI BIOTECHNOLOGY, REGENERON PHARMACEUTICALS, INC.
    Inventors: Martine Jasson, Vanessa Marks, Xiaohong Huang, Allen Radin
  • COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME
    Publication number: 20160280782
    Abstract: The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody that specifically binds human interleukin-6 receptor (hIL-6R).
    Type: Application
    Filed: November 21, 2014
    Publication date: September 29, 2016
    Inventors: Xiaohong Huang, Martine Jasson, Vanessa Marks, Allen Radin, Chungpeng Fan, Hubert Van Hoogstraten, Stefano Fiore, Janet Van Adelsberg, Mark Genovese
  • COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME
    Publication number: 20140302053
    Abstract: The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R) with a DMARD.
    Type: Application
    Filed: October 10, 2012
    Publication date: October 9, 2014
    Applicants: REGENERON PHARMACEUTICALS, INC., SANOFI
    Inventors: Xiaohong Huang, Martine Jasson, Vanessa Marks, Allen Radin
  • COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME
    Publication number: 20130149310
    Abstract: The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R).
    Type: Application
    Filed: October 10, 2012
    Publication date: June 13, 2013
    Applicants: REGENERON PHARMACEUTICALS Inc., SANOFI
    Inventors: Martine JASSON, Vanessa MARKS, Xiaohong HUANG, Allen RADIN